The Pediatric Cancer Program at City of Hope offers comprehensive, family-centered, leading-edge treatment for childhood, adolescent and young adult patients with neuroblastoma, Wilm's tumor and a wide variety of other benign and malignant solid tumors that require expert care to offer the best chance of cure.
Neuroblastoma represents both a diagnostic and treatment dilemma that requires expert understanding of the tumor’s biology. City of Hope has experience in both laboratory and patient care. It is this experience that offers the guidance of whether observation is appropriate or the most aggressive approach is necessary.
City of Hope is a member of the Children’s Oncology Group, which provides access to the nation’s largest group of pediatric and adolescent clinical trials for neuroblastoma with treatments that include chemotherapy, autologous hematopoietic stem cell transplant, retinoic acid therapy and antibody therapy (anti-Ch14.18) for aggressive neuroblastoma.
Several research initiatives at City of Hope are working to develop new therapies for neuroblastoma. Members of the pediatric team are collaborating on these research efforts to bring these therapies to clinical practice.
Wilm's tumor is a cancer of the kidney. What was once a deadly cancer is now survived by nearly 90 percent of patients. Deciding upon the correct treatment increases the chance of cure and requires expertise that only decades of experience can provide.
At City of Hope, our clinicians will guide you on the best course of treatment. Usually only surgery and chemotherapy are needed to successfully treat Wilm's tumor, but in difficult cases, more aggressive treatment, including radiation therapy, may needed.
Our long-standing expertise in autologous hematopoietic stem cell transplant enables aggressive treatment in patients with very advanced disease. City of Hope is a member of the Children’s Oncology Group, which provides access to the nation’s largest group of pediatric and adolescent clinical trials for Wilm's tumor.
Children, adolescents and young adults can have many other types of tumors. As a National Cancer Institute-designated comprehensive cancer center, the pediatric oncology team at City of Hope is prepared to deliver the best care available. We are a member of the Children’s Oncology Group, which provides access to the nation’s largest group of pediatric and adolescent clinical trials for the wide variety of cancer seen in children, adolescents and young adults. City of Hope offers expert treatment for the following diseases:
Our physicians are leading research to find better treatments for children, adolescents and young adults with these tumors. For more information on our pediatric research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.